VENTURE CAPITAL POST

☰

genetic diseases

⌂Back To Homepage Subscribe To RSS Feed
 Breaking News
  

Sanofi acquires 12pct in Alnylam Pharmaceuticals and drugs for $700M

Sanofi will be purchasing a 12% stake in Alnylam Pharmaceuticals as well as access to the drugs it has developed for rare diseases, Bloomberg reported.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Most Popular

Editor's pick

Must Read

 Breaking News
  
© 2022 Copyright Venture Capital Post. All Rights reserved.
Real Time Analytics